Get Healthy!

Popular Diabetes and Weight-loss Drug May Lower Alzheimer’s Risk

October 25, 2024
Susan Krivelow HealthDay Reporter

A new study finds type 2 diabetes patients taking semaglutide have much lower odds of developing Alzheimer’s disease, regardless of weight, gender or age.

Diabetes: Type II Diabetes: Misc.

Health News is provided as a service to Atlantic Pharmacy site users by HealthDay. Atlantic Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Patient Resources

Get Healthy!

Popular Diabetes and Weight-loss Drug May Lower Alzheimer’s Risk

Health News is provided as a service to Atlantic Pharmacy site users by HealthDay. Atlantic Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2024 HealthDay All Rights Reserved.

Share

Tags